498 related articles for article (PubMed ID: 12661312)
1. Razing the tollbooths. A call for restricting patents on basic biomedical research.
Stix G
Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
[No Abstract] [Full Text] [Related]
2. Taking the profit out of biomedical research tools.
Flores MA
Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness casts first shadows across US industry.
Waltz E
Nat Biotechnol; 2009 Mar; 27(3):211-2. PubMed ID: 19270651
[No Abstract] [Full Text] [Related]
4. Science and the law. Working through the patent problem.
Walsh JP; Cohen WM; Arora A
Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
[No Abstract] [Full Text] [Related]
5. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
6. Access to tangible research materials in biomedical research: conditions of access and their effect on research.
Monotti AL
J Law Med; 2006 Aug; 14(1):86-101. PubMed ID: 16937783
[TBL] [Abstract][Full Text] [Related]
7. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986.
Bulleit TN
J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568
[No Abstract] [Full Text] [Related]
8. Intellectual property issues in a clinical trial: a corporate perspective.
Fersko RS; Connolly MJ
Qual Assur; 1992 Jun; 1(3):237-48. PubMed ID: 1344679
[No Abstract] [Full Text] [Related]
9. The use of stem cells in biomedical research. Biotechnology Industry Organization (BIO) position statement.
Biotechnology Industry Organization
J Biolaw Bus; 1999; 3(1):40-4. PubMed ID: 11933970
[TBL] [Abstract][Full Text] [Related]
10. Industry and academia in transition.
Kennedy D
Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000
[No Abstract] [Full Text] [Related]
11. The stimulus package and medical therapeutics.
Somberg JC
Am J Ther; 2009; 16(2):105. PubMed ID: 19262356
[No Abstract] [Full Text] [Related]
12. U.S. science policy. NIH stimulus plan triggers flood of applications--and anxiety.
Kaiser J
Science; 2009 Apr; 324(5925):318-9. PubMed ID: 19372395
[No Abstract] [Full Text] [Related]
13. Research funding. Politics and funding in the U.S. public biomedical R&D system.
Hegde D; Mowery DC
Science; 2008 Dec; 322(5909):1797-8. PubMed ID: 19095928
[No Abstract] [Full Text] [Related]
14. Biomedical research. Stimulus funding elicits a tidal wave of 'challenge grants'.
Kaiser J
Science; 2009 May; 324(5929):867. PubMed ID: 19443754
[No Abstract] [Full Text] [Related]
15. Responding to stimuli.
Mahapatra A
ACS Chem Biol; 2009 Apr; 4(4):233. PubMed ID: 19371128
[No Abstract] [Full Text] [Related]
16. Regulating scientific research: intellectual property rights and the norms of science.
Rai AK
Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
[No Abstract] [Full Text] [Related]
17. Grant proposal reviewer says he would have scored proposal lower due to conflict of interest.
Maloney DM
Hum Res Rep; 2004 Dec; 19(12):8. PubMed ID: 15810180
[No Abstract] [Full Text] [Related]
18. Subverting U.S. health.
Los Angeles Times; 2003 Dec; ():M4. PubMed ID: 14971390
[No Abstract] [Full Text] [Related]
19. Patent medicine.
Baker D
J Public Health Policy; 2001; 22(3):275-9. PubMed ID: 11603309
[No Abstract] [Full Text] [Related]
20. SBIR program. Researchers fight against bigger slice to small business.
Mervis J
Science; 2009 Jul; 325(5936):18. PubMed ID: 19574355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
